APOGEE THERAPEUTICS INC (APGE) Stock Cash Flow
NASDAQ:APGE - Nasdaq - US03770N1019 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||
| Net Income | -182.15M | -83.98M | -39.78M | |||
| Depreciation Amortization | 189.00K | N/A | N/A | |||
| Change In Working Capital | -2.00M | 6.11M | 9.81M | |||
| Other non cash items | 12.79M | 3.12M | 13.54M | |||
| OPERATING CASH FLOW | -171.17M | -74.76M | -16.43M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||
| Capital Expenditure | -1.15M | -167.00K | N/A | |||
| Other Investing Activity | -299.31M | -273.74M | N/A | |||
| INVESTING CASH FLOW | -300.46M | -273.91M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||
| Stock Issued/Repurchased | 495.11M | 315.39M | 168.32M | |||
| FINANCING CASH FLOW | 495.11M | 315.39M | 168.32M | |||
| CHANGE IN CASH | 23.47M | -33.28M | 151.89M | |||
| FREE CASH FLOW | ||||||
| Operating Cash Flow | -171.17M | -74.76M | -16.43M | |||
| Capital Expenditure | -1.15M | -167.00K | N/A | |||
| FREE CASH FLOW | -172.33M | -74.93M | -16.43M | |||
All data in USD